Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Lee S Schwartzberg,1,2 Lincy S Lal,3 Sanjeev Balu,4 Kim Campbell,4 Lee Brekke,3 Caitlin Elliott,3 Stephanie Korrer3 1West Cancer Center, Memphis, TN, USA; 2Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA; 3Health Economics and Outcomes Research, Optum, Eden Prairie, MN...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2018-09-01
coleção:	ClinicoEconomics and Outcomes Research
Assuntos:	biosimilar pharmaceuticals febrile neutropenia filgrastim granulocyte colony-stimulating factor retrospective studies
Acesso em linha:	https://www.dovepress.com/incidence-of-febrile-neutropenia-during-chemotherapy-among-patients-wi-peer-reviewed-article-CEOR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!